Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation
Abstract Background Azithromycin, an antibiotic used for multiple infectious disorders, exhibits anti-inflammatory effects, but the molecular basis for this activity is not well characterized. Azithromycin inhibits IL-1β-mediated inflammation that is dependent, in part, on inflammasome activity. Her...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Respiratory Research |
Online Access: | http://link.springer.com/article/10.1186/s12931-017-0608-8 |
id |
doaj-59a510cff5804704bbedf50af922a9a0 |
---|---|
record_format |
Article |
spelling |
doaj-59a510cff5804704bbedf50af922a9a02020-11-24T21:09:56ZengBMCRespiratory Research1465-993X2017-06-011811810.1186/s12931-017-0608-8Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammationElizabeth A. Lendermon0Tiffany A. Coon1Joseph S. Bednash2Nathaniel M. Weathington3John F. McDyer4Rama K. Mallampalli5Pulmonary, Allergy, & Critical Care Medicine, Department of Medicine, University of PittsburghPulmonary, Allergy, & Critical Care Medicine, Department of Medicine, University of PittsburghPulmonary, Allergy, & Critical Care Medicine, Department of Medicine, University of PittsburghPulmonary, Allergy, & Critical Care Medicine, Department of Medicine, University of PittsburghPulmonary, Allergy, & Critical Care Medicine, Department of Medicine, University of PittsburghPulmonary, Allergy, & Critical Care Medicine, Department of Medicine, University of PittsburghAbstract Background Azithromycin, an antibiotic used for multiple infectious disorders, exhibits anti-inflammatory effects, but the molecular basis for this activity is not well characterized. Azithromycin inhibits IL-1β-mediated inflammation that is dependent, in part, on inflammasome activity. Here, we investigated the effects of azithromycin on the NACHT, LRR, and PYD domains-containing protein 3 (NALP3) protein, which is the sensing component of the NALP3 inflammasome, in human monocytes. Methods THP-1 cells were treated with azithromycin alone, LPS alone, or both. NALP3 and IL-1β protein levels were determined by immunoblotting. NLRP3 gene (encoding NALP3) transcript levels were determined by quantitative qPCR. In order to measure NLRP3 transcript decay, actinomycin D was used to impair gene transcription. THP-1 Lucia cells which contain an NF-κB responsive luciferase element were used to assess NF-κB activity in response to azithromycin, LPS, and azithromycin/LPS by measuring luminescence. To confirm azithromycin’s effects on NLRP3 mRNA and promoter activity conclusively, HEK cells were lipofected with luciferase reporter constructs harboring either the 5’ untranslated region (UTR) of the NLRP3 gene which included the promoter, the 3’ UTR of the gene, or an empty plasmid prior to treatment with azithromycin and/or LPS, and luminescence was measured. Results Azithromycin decreased IL-1β levels and reduced NALP3 protein levels in LPS-stimulated THP-1 monocytes through a mechanism involving decreased mRNA stability of the NALP3 – coding NLRP3 gene transcript as well as by decreasing NF-κB activity. Azithromycin accelerated NLRP3 transcript decay confirmed by mRNA stability and 3’UTR luciferase reporter assays, and yet the antibiotic had no effect on NLRP3 promoter activity in cells containing a 5’ UTR reporter. Conclusions These studies provide a unique mechanism whereby azithromycin exerts immunomodulatory actions in monocytes by destabilizing mRNA levels for a key inflammasome component, NALP3, leading to decreased IL-1β-mediated inflammation.http://link.springer.com/article/10.1186/s12931-017-0608-8 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Elizabeth A. Lendermon Tiffany A. Coon Joseph S. Bednash Nathaniel M. Weathington John F. McDyer Rama K. Mallampalli |
spellingShingle |
Elizabeth A. Lendermon Tiffany A. Coon Joseph S. Bednash Nathaniel M. Weathington John F. McDyer Rama K. Mallampalli Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation Respiratory Research |
author_facet |
Elizabeth A. Lendermon Tiffany A. Coon Joseph S. Bednash Nathaniel M. Weathington John F. McDyer Rama K. Mallampalli |
author_sort |
Elizabeth A. Lendermon |
title |
Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation |
title_short |
Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation |
title_full |
Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation |
title_fullStr |
Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation |
title_full_unstemmed |
Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation |
title_sort |
azithromycin decreases nalp3 mrna stability in monocytes to limit inflammasome-dependent inflammation |
publisher |
BMC |
series |
Respiratory Research |
issn |
1465-993X |
publishDate |
2017-06-01 |
description |
Abstract Background Azithromycin, an antibiotic used for multiple infectious disorders, exhibits anti-inflammatory effects, but the molecular basis for this activity is not well characterized. Azithromycin inhibits IL-1β-mediated inflammation that is dependent, in part, on inflammasome activity. Here, we investigated the effects of azithromycin on the NACHT, LRR, and PYD domains-containing protein 3 (NALP3) protein, which is the sensing component of the NALP3 inflammasome, in human monocytes. Methods THP-1 cells were treated with azithromycin alone, LPS alone, or both. NALP3 and IL-1β protein levels were determined by immunoblotting. NLRP3 gene (encoding NALP3) transcript levels were determined by quantitative qPCR. In order to measure NLRP3 transcript decay, actinomycin D was used to impair gene transcription. THP-1 Lucia cells which contain an NF-κB responsive luciferase element were used to assess NF-κB activity in response to azithromycin, LPS, and azithromycin/LPS by measuring luminescence. To confirm azithromycin’s effects on NLRP3 mRNA and promoter activity conclusively, HEK cells were lipofected with luciferase reporter constructs harboring either the 5’ untranslated region (UTR) of the NLRP3 gene which included the promoter, the 3’ UTR of the gene, or an empty plasmid prior to treatment with azithromycin and/or LPS, and luminescence was measured. Results Azithromycin decreased IL-1β levels and reduced NALP3 protein levels in LPS-stimulated THP-1 monocytes through a mechanism involving decreased mRNA stability of the NALP3 – coding NLRP3 gene transcript as well as by decreasing NF-κB activity. Azithromycin accelerated NLRP3 transcript decay confirmed by mRNA stability and 3’UTR luciferase reporter assays, and yet the antibiotic had no effect on NLRP3 promoter activity in cells containing a 5’ UTR reporter. Conclusions These studies provide a unique mechanism whereby azithromycin exerts immunomodulatory actions in monocytes by destabilizing mRNA levels for a key inflammasome component, NALP3, leading to decreased IL-1β-mediated inflammation. |
url |
http://link.springer.com/article/10.1186/s12931-017-0608-8 |
work_keys_str_mv |
AT elizabethalendermon azithromycindecreasesnalp3mrnastabilityinmonocytestolimitinflammasomedependentinflammation AT tiffanyacoon azithromycindecreasesnalp3mrnastabilityinmonocytestolimitinflammasomedependentinflammation AT josephsbednash azithromycindecreasesnalp3mrnastabilityinmonocytestolimitinflammasomedependentinflammation AT nathanielmweathington azithromycindecreasesnalp3mrnastabilityinmonocytestolimitinflammasomedependentinflammation AT johnfmcdyer azithromycindecreasesnalp3mrnastabilityinmonocytestolimitinflammasomedependentinflammation AT ramakmallampalli azithromycindecreasesnalp3mrnastabilityinmonocytestolimitinflammasomedependentinflammation |
_version_ |
1716756999856717824 |